Corton Capital’s Globus Medical GMED Stock Holding History

Corton Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,022	Closed	-$237K	–	274
2025 Q2	$237K	Buy	+4,022	New	+$260K	0.28%	155

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Corton Capital's GMED Position: Q3 2025 in Review

Corton Capital sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 4,022 shares — an estimated $237K sold.

Corton Capital first reported a position in GMED in Q2 2025 and held it in 1 quarter. The position peaked at $237K in Q2 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

Corton Capital reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
Corton Capital sold 4,022 Globus Medical shares in Q3 2025, an estimated $237K.
Corton Capital first reported a position in Globus Medical in Q2 2025 and held it in 1 quarter.
Corton Capital's Globus Medical position peaked at $237K in Q2 2025.
489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.